|
Volumn 293, Issue 3, 2002, Pages 945-952
|
APC0576, a novel inhibitor of NF-κB-dependent gene activation, prevents pro-inflammatory cytokine-induced chemokine production in human endothelial cells
a a a a a a a |
Author keywords
Chemokine; Endothelial cells; Human; NF B; Small molecule inhibitor
|
Indexed keywords
5 [(2,2 DIMETHYLCYCLOPROPANECARBONYL)AMINO] 2 [4 [(2,2 DIMETHYLCYCLOPROPANECARBONYL)AMINO]PHENOXY]PYRIDINE;
APC 0576;
APC 0579;
CHEMOKINE RECEPTOR;
CYTOKINE;
I KAPPA B ALPHA;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INTERLEUKIN 1;
INTERLEUKIN 8;
MESSENGER RNA;
MONOCYTE CHEMOTACTIC PROTEIN 1;
PYRIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
BIOASSAY;
CELL VIABILITY;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
DNA BINDING;
DNA DEGRADATION;
ENDOTHELIUM CELL;
GENE ACTIVATION;
HUMAN;
HUMAN CELL;
IMMUNITY;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
PROTEIN SYNTHESIS;
REGULATORY MECHANISM;
CELLS, CULTURED;
CHEMOKINES;
CYCLOPROPANES;
DNA-BINDING PROTEINS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOTHELIUM, VASCULAR;
GENES, REPORTER;
HUMANS;
I-KAPPA B PROTEINS;
INTERLEUKIN-1;
NF-KAPPA B;
PYRIDINES;
TRANS-ACTIVATION (GENETICS);
TRANSCRIPTION FACTOR RELA;
|
EID: 0036290384
PISSN: 0006291X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0006-291X(02)00322-4 Document Type: Article |
Times cited : (9)
|
References (37)
|